Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.
作者信息
Moës Bastien, Rudd Christopher E
机构信息
Department of Medicine, Université de Montréal, Montréal, QC, H3C 3J7, Canada.
Department of Microbiology, Infection and Immunology, Université de Montréal, Montreal, QC, Canada.
出版信息
Cell Mol Immunol. 2025 May;22(5):557-558. doi: 10.1038/s41423-025-01277-8. Epub 2025 Apr 2.
Abstract
摘要
相似文献
1
Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.评论：糖原合酶激酶3通过调节NFAT激活来控制T细胞耗竭。
Cell Mol Immunol. 2025 May;22(5):557-558. doi: 10.1038/s41423-025-01277-8. Epub 2025 Apr 2.
2
Reply to 'Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation'.对《关于糖原合酶激酶3通过调节NFAT激活来控制T细胞耗竭的评论》的回复
Cell Mol Immunol. 2025 May;22(5):559-562. doi: 10.1038/s41423-025-01280-z. Epub 2025 Apr 2.
3
Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.糖原合成酶激酶 3 通过调节 NFAT 的激活来控制 T 细胞衰竭。
Cell Mol Immunol. 2023 Oct;20(10):1127-1139. doi: 10.1038/s41423-023-01075-0. Epub 2023 Aug 9.
4
Nerve growth factor (NGF) regulates activity of nuclear factor of activated T-cells (NFAT) in neurons via the phosphatidylinositol 3-kinase (PI3K)-Akt-glycogen synthase kinase 3β (GSK3β) pathway.神经生长因子（NGF）通过磷脂酰肌醇 3-激酶（PI3K）-Akt-糖原合成酶激酶 3β（GSK3β）途径调节神经元中活化 T 细胞核因子（NFAT）的活性。
J Biol Chem. 2014 Nov 7;289(45):31349-60. doi: 10.1074/jbc.M114.587188. Epub 2014 Sep 17.
5
Endothelial cells stimulate T cell NFAT nuclear translocation in the presence of cyclosporin A: involvement of the wnt/glycogen synthase kinase-3 beta pathway.在内皮细胞存在的情况下，环孢素A可刺激T细胞中活化T细胞核因子（NFAT）的核转位：Wnt/糖原合酶激酶-3β信号通路的参与
J Immunol. 2002 Oct 1;169(7):3717-25. doi: 10.4049/jimmunol.169.7.3717.
6
Regulation of the NFAT pathway discriminates CD4+CD25+ regulatory T cells from CD4+CD25- helper T cells.NFAT信号通路的调节可区分CD4+CD25+调节性T细胞与CD4+CD25-辅助性T细胞。
J Leukoc Biol. 2008 Mar;83(3):708-17. doi: 10.1189/jlb.0507321. Epub 2007 Nov 21.
7
Connective tissue growth factor (CTGF) transactivates nuclear factor of activated T-cells (NFAT) in cells of the osteoblastic lineage.结缔组织生长因子 (CTGF) 在成骨细胞系细胞中转激活 T 细胞活化核因子 (NFAT)。
J Cell Biochem. 2010 May 15;110(2):477-83. doi: 10.1002/jcb.22561.
8
Distinct activation properties of the nuclear factor of activated T-cells (NFAT) isoforms NFATc3 and NFATc4 in neurons.神经元中激活的 T 细胞核因子（NFAT）异构体 NFATc3 和 NFATc4 的独特激活特性。
J Biol Chem. 2012 Nov 2;287(45):37594-609. doi: 10.1074/jbc.M112.365197. Epub 2012 Sep 12.
9
Akt/protein kinase b and glycogen synthase kinase-3beta signaling pathway regulates cell migration through the NFAT1 transcription factor.Akt/蛋白激酶b和糖原合酶激酶-3β信号通路通过NFAT1转录因子调节细胞迁移。
Mol Cancer Res. 2009 Mar;7(3):425-32. doi: 10.1158/1541-7786.MCR-08-0342. Epub 2009 Mar 3.
10
Polycystin-1 activates the calcineurin/NFAT (nuclear factor of activated T-cells) signaling pathway.多囊蛋白-1激活钙调神经磷酸酶/活化T细胞核因子（NFAT）信号通路。
J Biol Chem. 2004 Dec 31;279(53):55455-64. doi: 10.1074/jbc.M402905200. Epub 2004 Oct 5.
本文引用的文献
1
Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.糖原合成酶激酶 3 通过调节 NFAT 的激活来控制 T 细胞衰竭。
Cell Mol Immunol. 2023 Oct;20(10):1127-1139. doi: 10.1038/s41423-023-01075-0. Epub 2023 Aug 9.
2
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.GSK-3 抑制剂 Elraglusib 增强肿瘤活检中肿瘤浸润免疫细胞的激活，并与抗 PD-L1 在结直肠癌的小鼠模型中协同作用。
Int J Mol Sci. 2023 Jun 29;24(13):10870. doi: 10.3390/ijms241310870.
3
Glycogen synthase kinase 3 drives thymocyte egress by suppressing β-catenin activation of Akt.糖原合酶激酶3通过抑制Akt的β-连环蛋白激活来驱动胸腺细胞迁出。
Sci Adv. 2021 Oct 8;7(41):eabg6262. doi: 10.1126/sciadv.abg6262.
4
The GSK3β-β-catenin-TCF1 pathway improves naive T cell activation in old adults by upregulating miR-181a.GSK3β-β-连环蛋白-TCF1通路通过上调miR-181a改善老年人初始T细胞的激活。
NPJ Aging Mech Dis. 2021 Feb 8;7(1):4. doi: 10.1038/s41514-021-00056-9.
5
Commentary: Small Molecule Inhibition of PD-1 Transcription is an Effective Alternative to Antibody Blockade in Cancer Therapy.评论：小分子抑制PD-1转录是癌症治疗中抗体阻断的有效替代方法。
J Immunol Sci. 2019 May 7;3(1):9-12. doi: 10.29245/2578-3009/2019/1.1167.
6
Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells.糖原合酶激酶 3 的抑制作用降低了 PD-1 的表达，促进了抗原特异性 CAR-T 细胞的长期存活和记忆生成。
Cancer Lett. 2018 Oct 1;433:131-139. doi: 10.1016/j.canlet.2018.06.035. Epub 2018 Jun 27.
7
Glycogen Synthase Kinase 3 Inactivation Compensates for the Lack of CD28 in the Priming of CD8 Cytotoxic T-Cells: Implications for anti-PD-1 Immunotherapy.糖原合酶激酶3失活可弥补CD8细胞毒性T细胞启动过程中CD28的缺失：对抗PD-1免疫疗法的启示。
Front Immunol. 2017 Dec 11;8:1653. doi: 10.3389/fimmu.2017.01653. eCollection 2017.
8
Glycogen Synthase Kinase 3 Inactivation Drives T-bet-Mediated Downregulation of Co-receptor PD-1 to Enhance CD8(+) Cytolytic T Cell Responses.糖原合酶激酶3失活驱动T-bet介导的共受体PD-1下调以增强CD8(+) 细胞毒性T细胞反应。
Immunity. 2016 Feb 16;44(2):274-86. doi: 10.1016/j.immuni.2016.01.018.
9
T cell exhaustion.T 细胞耗竭。
Nat Immunol. 2011 Jun;12(6):492-9. doi: 10.1038/ni.2035.
10
Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance.颗粒酶B和穿孔素对于调节性T细胞介导的肿瘤清除抑制作用很重要。
Immunity. 2007 Oct;27(4):635-46. doi: 10.1016/j.immuni.2007.08.014. Epub 2007 Oct 4.
Zotero 插件